IP Library › Granted Patent US 9,868,966
Granted Patent B2
US 9,868,966 · App. 14/435,111 · Granted Jan 16, 2018

Genetically engineered yeast

Inventors: Irina Borodina (Kgs. Lyngby, DK); Kanchana Rueksomtawin Kildegaard (Kgs. Lyngby, DK); Jochen Förster (Kgs. Lyngby, DK); Fredrik Öberg (Kgs. Lyngby, DK)
Assignee: TECHNICAL UNIVERSITY OF DENMARK
C12P7/42C12N9/0006C12N9/1096C12N9/88C12N9/93C12P7/52C12Y101/01031C12Y101/01059C12Y206/01001C12Y401/01011C12Y401/01015C12Y604/01001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,868,966
App. No.
14/435,111
Granted
Jan 16, 2018
Kind
B2
Abstract

A genetically modified Saccharomyces cerevisiae including an active fermentation pathway producing 3-HP expresses an exogenous gene expressing the aminotransferase YhxA from Bacillus cereus AH1272 catalyzing a transamination reaction between beta-alanine and pyruvate to produce malonate semialdehyde. The yeast may also express a 3-hydroxyisobutyrate dehydrogenase (HIBADH) and a 3-hydroxypropanoate dehydrogenase (3-HPDH) and aspartate 1-decarboxylase. Additionally the yeast may express pyruvate carboxylase and aspartate aminotransferase.

Claims (8)

1. A genetically modified yeast cell comprising an enhanced-fermentation pathway for producing 3-hydroxypropionic acid (3HP), wherein the fermentation pathway includes an enzyme having at least 85% identity with SEQ ID NO: 1, and catalysing a transamination reaction between beta-alanine and pyruvate to produce malonate semialdehyde, and wherein said enzyme is the expression product of an exogenous gene that is expressed by the genetically modified yeast cell.

2. A genetically modified yeast cell as claimed in claim 1 , wherein said enzyme is the aminotransferase YhxA from Bacillus cereus AH1272.

3. A genetically modified yeast cell as claimed in claim 1 , expressing a 3-hydroxyisobutyrate dehydrogenase (HIBADH).

4. A genetically modified yeast cell as claimed in claim 3 , wherein said HIBADH is from Pseudomonas aeruginosa, P. putida, Bacillus cereus , or Candida albicans.

5. A genetically modified yeast cell as claimed in claim 1 , wherein the yeast is S. cerevisiae.

6. A method for the production of 3HP comprising culturing the modified yeast cell according to claim 1 and recovering 3HP from the culture.

7. A method as claimed in claim 6 , comprising supplying said culture with beta-alanine and/or L-aspartate.

8. A method as claimed in claim 6 , wherein at least 100 mg of 3HP per liter of culture medium is produced or is recovered from said culture medium.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2015
From: BORODINA, IRINA; KILDEGAARD, KANCHANA RUEKSOMTAWIN; FORSTER, JOCHEN; OBERG, FREDRIK
To: TECHNICAL UNIVERSITY OF DENMARK
Reel/Frame 035816/0759 →
Priority Claims (1)
EP 12188198 · Oct 11, 2012 · regional
Continuity (1)
Related Publication 20150267228A1 · Sep 24, 2015